This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
On February 22, 2011, in the case of Bruesewitz v Wyeth,1 the US Supreme Court preserved the crucial role of the National Childhood Vaccine Injury Act (NCVIA) in ensuring the continuing availability of children's vaccines in the United States. Although at first glance the Bruesewitz case may seem to be simply a technical decision that addressed the legal intricacies of products liability law, the case has important implications for pediatricians, their patients, and the continuity of our vaccine supply.
By the 1980s, vaccines had become so successful at preventing many infectious diseases that the public was becoming much less alarmed by those diseases2 and much more concerned with the risk of injury from the vaccines themselves.3 As a result, the number of lawsuits alleging vaccine-related injuries exploded, driving manufacturers from the market and producing vaccine shortages. In 1986, the US Congress enacted …
Address correspondence to Gary N. McAbee, DO, JD, Department of Neuroscience, New Jersey Neuroscience Institute, 65 James St, Edison, NJ 08818. E-mail: gmcabee{at}solarishs.org
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.